health.yahoo.com
Cure8 news brief
Why This Matters
Biologics are commonly recommended for moderate-to-severe Crohn's disease and can change disease course by healing inflammation, so understanding their benefits, risks, and cost/access issues helps patients make informed decisions.
The article also clarifies misconceptions about safety (vs steroids) and explains biosimilars as lower-cost options.
Who Should Pay Attention
Adult patients with moderate-to-severe Crohn's disease; people considering biologic therapy; caregivers and clinicians involved in Crohn's treatment decisions.
Study Snapshot
Story typeMainstream News
Evidence typePatient Education
Source depthFull source text
What To Know
Biologics are advanced therapies that target specific immune proteins to reduce gut inflammation and help the intestinal lining heal; they are recommended as first-line treatment for many people with moderate-to-severe Crohn's disease per guideline-based practice.
The article names approved biologic medications (including anti-TNF agents, IL-12/23 and IL-23 inhibitors, and an anti-integrin) and explains that biosimilars can offer equivalent effectiveness at lower cost.
The piece contrasts biologics with steroids: steroids are useful short-term for flares but carry substantial long-term side effects, whereas biologics are intended for longer-term disease control though they can increase infection risk and require monitoring. It also highlights insurance step-therapy and prior-authorization barriers as common access issues.
Keep In Mind
The article is a patient-facing education piece summarizing guidelines and expert opinions; it is not a clinical study. It references guideline recommendations and an analysis of studies but does not present new trial data.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationhealth.yahoo.com
Publishereverydayhealth.com
AuthorsMarygrace Taylor
Indexed viaGoogle News
Source typeWeb article
PublishedSep 16, 2026, 9:21 PM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
When are biologic drugs an option for Crohn’s disease?
Biologics are a common and important treatment option for people with moderate to severe Crohn’s disease; knowing when they’re used and their potential risks helps patients discuss treatment choices with their care team.
VIDEO: Longstanding therapies, recent approvals provide options in Crohn’s disease
This video quickly outlines the range of medical treatments now available for Crohn’s disease, including newer approvals. Knowing drug classes and recent options can help patients and clinicians discuss treatment plans...
To Your Good Health: Aggressive treatment for Crohn's - Tribune Chronicle -
Guidelines recommend treating objective inflammation even when symptoms are mild because untreated disease can cause complications; the article describes escalation to risankizumab due to endoscopic inflammation, high...